Meta AnalysisID 8029
维生素D治疗自身免疫性和风湿性疾病的有效性和安全性
CRD42023470087
To explore the evidence of effectiveness and safety of Vitamin D in Autoimmune and Rheumatic Diseases
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 8029
- Evidence Id
- 16587
- Core Evidence Id
- 16587
- Source Meta Analysis Id
- 8029
- Herb2 Meta Analysis Id
- HBMA008029
- Crd Id
- CRD42023470087
- Title
- Effectiveness and safety of Vitamin D in Autoimmune and Rheumatic Diseases
- Review Question
- To explore the evidence of effectiveness and safety of Vitamin D in Autoimmune and Rheumatic Diseases
- Study Type Included
- Randomized control trials will be included to assess the effect of Vitamin D in Autoimmune and Rheumatic Diseases
- Condition Being Studied
- Autoimmune and Rheumatic Diseases Vitamin D in Autoimmune and Rheumatic Diseases
- Participant
- Inclusion: 1) Randomized controlled trials (RCTs), no limits on the way to randomization generation, blinding or publishing language; 2) Human with specified diagnosis criteria of Autoimmune and Rheumatic Diseases that are clearly diagnosed by recognized standards.; 3) Interventional therapies was Vitamin D; control therapies included blank, placebo, and western medicine
- Animal
- Human Disease Modelled
- Intervention
- Intervention included Vitamin D, no limit to dosage form, frequency and dosage. And intervention could be only Vitamin D, Vitamin D plus conventional therapy and so on.
- Comparator Control
- Control included placebo, conventional therapy, and other therapy that did not involve in Vitamin D in Autoimmune and Rheumatic Diseases
- Main Outcome
- The main outcomes include improvement in clinical symptoms, improvement in biochemistry, improvement in intestinal microbiota and adverse events. Measures of effect Mean difference (MD) and relative risks (RR)
- Outcome Measure
- Additional Outcome
- The additional outcomes include Inflammatory immune response indicators, other biochemical indicators Measures of effect Mean difference (MD) and relative risks (RR)
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Cholestanes; Humans; Rheumatic Diseases; Vitamin D; Vitamins
- Contact
- Kailin Yang [email protected]
- Organisational Affiliation
- Hunan University of Chinese Medicine
- Funding Source
- NO
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-10-06
- Registration Date
- 2023-10-17
- Anticipated Start Date
- 2023-10-07
- Anticipated Completion Date
- 2024-07-25
- Title Cn
- 维生素D治疗自身免疫性和风湿性疾病的有效性和安全性
- Title En
- Effectiveness and safety of Vitamin D in Autoimmune and Rheumatic Diseases
- Bilingual Status
- complete